At-Risk Women Unlikely to Take Tamoxifen
CBSSM's Co-director Angela Fagerlin, PhD, is the lead author on a study showing that women at high risk for breast cancer are unlikely to choose the drug tamoxifen, even if they are well informed about its benefits. Dr. Fagerlin's research has received wide media attention. For a press release summarizing the data, click here
Additional authors on the article, which appeared in the online journal Breast Cancer Research and Treatment, are Brian Zikmund-Fisher, Dylan Smith, Vijayan Nair, Holly Derry, Paula
Lantz, Daniel Hayes, Rosemarie Pitsch, Aleksandra Jankovic, and Peter Ubel from the University of Michigan; Jennifer McClure, Sarah Greene, and Cheryl Wiese from Group Health
Center for Health Studies in Seattle; Azadeh Stark, Sharon Hensley
Alford, and Sarah Claud Zweig from Henry Ford Health System in Detroit.
Related Topics:
Decision aids, Risk communication, Cancer - breast
Keywords:
Brian Zikmund-Fisher, PhD
Brian J. Zikmund-Fisher is an Assistant Professor in the Department of Health Behavior and Health Education, University of Michigan School of Public Health, as well as a Research Assistant Professor in the Division of General Internal Medicine, University of Michigan Medical School. He is...
Dylan Smith, PhD
Dylan Smith studied social psychology at Arizona State University, where his work focused on interpersonal and intergroup relations and evolutionary psychology. His current research seeks to translate theoretical and methodological advances in the behavioral sciences to the study of health-related...
Angela Fagerlin, PhD
Angie Fagerlin studied psychology and literature at Hope College and received her PhD in experimental (cognitive) psychology at Kent State University. Her primary research focus is testing methods for communicating the risks and benefits of treatment to patients (e.g., in decision aids). Her other...
